Pharmaceuticals - Community Register


Community list of not active orphan medicinal products


Product information


EU orphan designation number: EU/3/09/646
Active ingredient: Talampanel
Indication: Treatment of amyotrophic lateral sclerosis
Sponsor: Teva Pharma GmbH
Kandelstrasse 10, D-79199 Kirchzarten, Deutschland

   Public summary of scientific opinion    


European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
16/06/2009 Centralised Orphan - Designation EMEA/OD/012/09 (2009)4684 of 12/06/2009
26/08/2010 Centralised Orphan - Removal of orphan designation from Community Register